Sustained release compositions of 4-aminopyridine
The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
09.07.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders. |
|---|---|
| AbstractList | The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders. |
| Author | Gold, Thomas B Way, Susan L D'Souza, Rohini Cobb, Jr., Joseph E |
| Author_xml | – fullname: Cobb, Jr., Joseph E – fullname: Way, Susan L – fullname: D'Souza, Rohini – fullname: Gold, Thomas B |
| BookMark | eNrjYmDJy89L5WQwDC4tLknMzEtNUShKzUlNLE5VSM7PLcgvzizJzM8rVshPUzDRTczNzMsvqCzKTAEq5GFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhkYGRpYWRgZORsbEqAEAuFkt4A |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US12029820B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US12029820B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 26 04:35:29 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US12029820B23 |
| Notes | Application Number: US202117374285 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240709&DB=EPODOC&CC=US&NR=12029820B2 |
| ParticipantIDs | epo_espacenet_US12029820B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20240709 |
| PublicationDateYYYYMMDD | 2024-07-09 |
| PublicationDate_xml | – month: 07 year: 2024 text: 20240709 day: 09 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | Acorda Therapeutics, Inc |
| RelatedCompanies_xml | – name: Acorda Therapeutics, Inc |
| Score | 3.5563028 |
| Snippet | The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Sustained release compositions of 4-aminopyridine |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240709&DB=EPODOC&locale=&CC=US&NR=12029820B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6LzgwrSt2LXj7V5KEK_GILbsKvsbTRdCh3Ylq0y9t97ia3zRd9CApfk4HL5Jb-7A3jUmU0tnWaKbVJVMYwkVRLT5qiVaalpaYiKBNtiPBzFxsvcnHdg1cbCiDyhW5EcES0qRXuvxXld7R-xfMGt3DzRHLvK53Dm-HKDjjk8UYnsu04wnfgTT_Y8J47k8Zsz0HiucU118bg-wGu0xelfwbvLo1Kq3y4lPIXDKUor6jPosKIHx15bea0HR6_Nhzc2G9vbnMMg-o51YkuJFzpB7yNxPnhLupLKTDKU5CMvymq3ztElsQt4CIOZN1Jw7sXPRhdxtF-mfgndoizYFUh0aHMkQBKSWYhmM0JSqhFTz3QjJcxaXkP_bzn9_wZv4IQrTdBPyS106_Unu0MnW9N7oZ0vpt2AZw |
| link.rule.ids | 230,309,783,888,25578,76884 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTkXnVwXpW7Hrx9o8FGFtx9StG7aVvZWmS6GC7dgq4n_vJW7OF30LCVySg8vll_zuDuBWZza1dJortklVxTDSTElNm6NWpmWmpSEqEmyLoDeMjceZOWvA6yYWRuQJ_RDJEdGiMrT3WpzXi-0jlie4las7WmBXdT-IHE9eo2MOT1Qie33Hn068iSu7rhOHcvDsdDWea1xT-3hc7-AV2-Z59v2XPo9KWfx2KYMD2J2itLI-hAYr29ByN5XX2rA3Xn94Y3Nte6sj6IbfsU5sLvFCJ-h9JM4H35CupCqXDCV9K8pq8bks0CWxY7gZ-JE7VHDu5GejSRxul6mfQLOsSnYKEu3ZHAmQlOQWotmckIxqxNRz3cgIs-Zn0PlbTue_wWtoDaPxKBk9BE_nsM8VKKio5AKa9fKdXaLDremV0NQX07WDVw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Sustained+release+compositions+of+4-aminopyridine&rft.inventor=Cobb%2C+Jr.%2C+Joseph+E&rft.inventor=Way%2C+Susan+L&rft.inventor=D%27Souza%2C+Rohini&rft.inventor=Gold%2C+Thomas+B&rft.date=2024-07-09&rft.externalDBID=B2&rft.externalDocID=US12029820B2 |